Risk Of Rv Dysfunction Following Heart Transplantation: Donor Organ Temperature Matters!
Nir Uriel,Jeff Teuteberg,Scott Silvestry,Marzia Leacche,Jacob Schroder,Yasuhiro Shudo,Dan Meyer,Masashi Kawabori,Koji Takeda,Mary Jacoski,David D'Alessandro,Adam DeVore
DOI: https://doi.org/10.1016/j.cardfail.2023.10.049
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Purpose Traditional ice storage (ICE) results in uneven and unpredictable preservation temperatures, putting the graft at risk for cellular injury from freezing or during prolonged procurement times. In contrast, the Paragonix SherpaPak Cardiac Transport System (SCTS) maintains donor heart temperatures between 4°C - 8°C, which may minimize this injury. Data from the GUARDIAN-Heart Registry has shown the SCTS significantly reduces the risk of severe PGD compared to traditional ice storage. We sought to determine if there was a similar benefit of the SCTS on the incidence of severe right ventricular (RV) dysfunction. Methods The GUARDIAN-Heart registry is a global, multicenter, retrospective registry assessing outcomes after heart transplant comparing SCTS and ICE donor heart storage. Over 1000 patients transplanted at 15 U.S. centers were propensity matched on site, ischemic time, donor age, baseline LVAD and transplant era (pre/post 2018 UNOS allocation changes). R Statistical Software was used for analyses. Results Propensity matching resulted in a total of 562 patients, SCTS (n=281) vs ICE (n=281). Between the two groups baseline recipient characteristics were similar and donor characteristics were similar, but the SCTS cohort had a significantly longer procurement distance (see Table 1). As shown in Table 2, post-transplant SCTS patients had a 50% reduction in severe PGD (12.1% ICE vs 6.0% SCTS, p = 0.018), as well as a 54% reduction in site-reported severe RV dysfunction (10.8% ICE vs 5.0% SCTS, p = 0.020), and a higher incidence of normal RV function (44.5% ICE vs 53.9%, p = 0.034). The inotrope score was also reduced (15.2 ICE vs 13.3 SCTS, p = 0.043). There was a numerically lower, but non-significant difference in the rate of moderate RV dysfunction (20.4% ICE vs 14.7% SCTS, p = 0.10). Among those with severe RV dysfunction, there was no difference in one-year survival by donor storage (84.2% ICE vs 92.9% SCTS, p = 0.25); however, there was a trend towards higher overall survival with SCTS (92.1% ICE vs 95.9% SCTS, p = 0.07). Conclusions Use of the SherpaPak CTS was associated with significant reductions in post-transplant severe right ventricular dysfunction and overall inotrope score compared to ice storage. These data support the growing evidence that controlled hypothermic organ preservation results in improved post-transplant outcomes.
cardiac & cardiovascular systems